GAFFX
Price
$88.27
Change
+$0.61 (+0.70%)
Updated
Aug 25 closing price
Net Assets
342.42B
GLCTX
Price
$31.94
Change
+$0.17 (+0.54%)
Updated
Aug 25 closing price
Net Assets
1.64B
Interact to see
Advertisement

GAFFX vs GLCTX

GAFFX vs GLCTX Comparison Chart in %
View a ticker or compare two or three
VS
GAFFX vs. GLCTX commentary
Aug 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and GLCTX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 342B vs. GLCTX (1.64B). GAFFX pays higher dividends than GLCTX: GAFFX (0.53) vs GLCTX (0.00). GAFFX was incepted earlier than GLCTX: GAFFX (10 years) vs GLCTX (19 years). GLCTX (0.68) is less costly to investors than GAFFX (0.29). GLCTX is a more actively managed with annual turnover of: 209.00 vs. GAFFX (32.00). GLCTX has a lower initial minimum investment than GAFFX: GLCTX (0) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 4.43 vs. GLCTX (-2.55). GAFFX return over 5 years is better than : 17.12 vs. GLCTX (-31.40).
GAFFXGLCTXGAFFX / GLCTX
Total Expense Ratio0.290.6545%
Annual Report Gross Expense Ratio0.290.6843%
Fund Existence10 years19 years-
Gain YTD9.679-0.781-1,240%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets342B1.64B20,905%
Annual Yield % from dividends0.530.00-
Returns for 1 year4.43-2.55-174%
Returns for 3 years48.9531.17157%
Returns for 5 years17.12-31.40-55%
Returns for 10 yearsN/A38.27-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GNWRX29.170.12
+0.41%
Nationwide R
VSFSX30.310.02
+0.07%
Federated Hermes MDT Small Cap Value R6
VIVAX88.45N/A
N/A
Vanguard MStar Value Index Investor
GLVCX72.25N/A
N/A
Invesco Global Focus C
FTXNX65.36N/A
N/A
FullerThaler Behavioral Sm-Cp Gr Inv